Smith and Nephew
-
Sports Medicine
New study shows 96% healing of hard to treat large and massive rotator cuff tears with Smith+Nephew’s REGENETEN™ Bioinductive Implant
LONDON, Nov. 19, 2019 /PRNewswire/ — Smith+Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announces a new clinical study illustrating the…
Read More » -
Recon
Smith+Nephew launches industry-first OR3O™ Dual Mobility System utilising unique OXINIUM™ DH metal alloy for use in primary and revision hip arthroplasty
LONDON, Nov. 8, 2019 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility…
Read More » -
Recon
Smith+Nephew announces change of Chief Executive Officer
21 October 2019 Smith+Nephew (LSE:SN, NYSE:SNN) today announces that Namal Nawana will step down from the Board and his position…
Read More » -
Sports Medicine
Smith+Nephew’s NOVOSTITCH™ Meniscal Repair System shows 91.7% success rate in “STITCH” Study at one-year follow-up
LONDON, Oct. 9, 2019 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, is pleased to announce results for its NOVOSTITCH Meniscal…
Read More » -
Recon
Smith+Nephew introduces ground-breaking assurance program for TRIGEN™ INTERTAN™ Intertrochanteric Hip Fracture Nail
LONDON, Sept. 26, 2019 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announced the launch of its new INTERTAN Product…
Read More » -
Extremities
Smith+Nephew launches LENS 4K Surgical Imaging System
LONDON, Sept. 24, 2019 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces the launch of its LENS 4K Surgical Imaging System; a…
Read More » -
Extremities
Smith+Nephew launches new EVOS™ WRIST Plating System; an evolutionary treatment option for both simple and complex wrist fractures
LONDON, Sept. 5, 2019 /PRNewswire/ — Smith+Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announced the launch of its EVOS WRIST…
Read More » -
Recon
Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears
LONDON, July 11, 2019 /PRNewswire/ — Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of…
Read More » -
Recon
Smith & Nephew Launches the CONQUEST FN™ Femoral Neck Fracture System, a Fresh Approach to Hip Preservation Versus Current Treatment Options
LONDON, June 5, 2019 /PRNewswire/ — Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, has announced the launch of its…
Read More » -
Recon
Smith & Nephew announces completion of Brainlab Orthopaedic Joint Reconstruction Business acquisition
3 June 2019 Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces it has completed the…
Read More » -
Recon
Smith & Nephew’s OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020
LONDON, May 22, 2019 /PRNewswire/ — Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today presented new data at…
Read More » -
Sports Medicine
Smith & Nephew launches new FLOW 90™ Wand at ISAKOS joining its innovative collection of COBLATION™ technology and shoulder repair portfolios
LONDON, May 13, 2019 /PRNewswire/ — Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announces the U.S. launch of…
Read More » -
Financial
Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc
COLUMBIA, Md., April 17, 2019 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing…
Read More » -
Financial
Smith & Nephew acquires developer of unique pressure injury prevention device, Leaf Healthcare, Inc.
1 April 2019 Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces that it has agreed to…
Read More » -
Financial
Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.
LONDON, March 12, 2019 /PRNewswire/ — Smith & Nephew plc (LSE: SN,NYSE: SNN), the global medical technology business, announces that it has agreed to…
Read More »